Opaleye Management Inc. - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 2 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$4,583,000
+352.9%
760,000
+176.4%
0.90%
+249.8%
Q3 2018$1,012,000
-75.1%
275,000
-74.9%
0.26%
-77.9%
Q1 2018$4,063,000
+220.7%
1,095,100
+148.9%
1.16%
+186.2%
Q4 2017$1,267,000440,0000.41%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders